The impact of specific oxidized amino acids on protein turnover in J774 cells.
暂无分享,去创建一个
[1] K. Uchida,et al. Metal-catalyzed oxidation of protein-bound dopamine. , 2006, Biochemistry.
[2] R. Dean,et al. Evidence for L‐dopa incorporation into cell proteins in patients treated with levodopa , 2006, Journal of neurochemistry.
[3] C. Karakukcu,et al. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis , 2006, Cell biochemistry and function.
[4] Barry Halliwell,et al. Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.
[5] Jens Dreyhaupt,et al. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. , 2006, Investigative ophthalmology & visual science.
[6] T. Siddique,et al. Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[7] E. Bigio,et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] Z. Guo,et al. Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[9] S. Pennathur,et al. Misincorporation of free m-tyrosine into cellular proteins: a potential cytotoxic mechanism for oxidized amino acids. , 2006, The Biochemical journal.
[10] D. Pearce,et al. You say lipofuscin, we say ceroid: Defining autofluorescent storage material , 2006, Neurobiology of Aging.
[11] A. Ciechanover. Intracellular Protein Degradation: From a Vague Idea Thru the Lysosome and the Ubiquitin-Proteasome System and onto Human Diseases and Drug Targeting* * , 2006, Cell death and differentiation.
[12] R. Dean,et al. Translational incorporation of L‐3,4‐dihydroxyphenylalanine into proteins , 2005, The FEBS journal.
[13] I. Wittmann,et al. Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase , 2005, Free radical research.
[14] A. Goldberg,et al. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. , 2005, Methods in enzymology.
[15] E. Kominami,et al. Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged , 2005, Virchows Archiv A.
[16] R. Dean,et al. Biosynthesis and turnover of DOPA-containing proteins by human cells. , 2004, Free radical biology & medicine.
[17] M. Ruberg,et al. Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system , 2004, Journal of neurochemistry.
[18] E. Stadtman. Role of oxidant species in aging. , 2004, Current medicinal chemistry.
[19] R. Dean,et al. Proteolytic 'defences' and the accumulation of oxidized polypeptides in cataractogenesis and atherogenesis. , 2003, Biochemical Society symposium.
[20] M. Davies,et al. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. , 2003, The Biochemical journal.
[21] T. Iwaki,et al. Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis , 2003, Acta Neuropathologica.
[22] U. Brunk,et al. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. , 2002, Free radical biology & medicine.
[23] R. Dean,et al. Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. , 2002, Toxicology.
[24] R. Dean,et al. Biosynthetic incorporation of oxidized amino acids into proteins and their cellular proteolysis. , 2002, Free radical biology & medicine.
[25] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[26] E. Stadtman,et al. Protein Oxidation in Aging and Age‐Related Diseases , 2001, Annals of the New York Academy of Sciences.
[27] R. Dean,et al. Metabolism of protein-bound DOPA in mammals. , 2000, The international journal of biochemistry & cell biology.
[28] T. Grune,et al. Proteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts , 1998, FEBS letters.
[29] R. Dean,et al. The Hydroxyl Radical in Lens Nuclear Cataractogenesis* , 1998, The Journal of Biological Chemistry.
[30] R. Dean,et al. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. , 1998, The Biochemical journal.
[31] R. Dean,et al. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. , 1998, The Biochemical journal.
[32] E. Nilsson,et al. Preparation of artificial ceroid/lipofuscin by UV-oxidation of subcellular organelles , 1997, Mechanisms of Ageing and Development.
[33] J. Longhurst,et al. Hydroxyl radical production during myocardial ischemia and reperfusion in cats. , 1996, The American journal of physiology.
[34] T. Reinheckel,et al. Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.
[35] K. Davies,et al. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1994, Archives of biochemistry and biophysics.
[36] R. Nixon,et al. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.
[37] R. Bolli,et al. Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. , 1993, Circulation research.
[38] K. Davies,et al. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1993, The Journal of biological chemistry.
[39] R. Dean,et al. Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. , 1993, Biochemistry.
[40] P. Gallop,et al. Specific detection of quinoproteins by redox-cycling staining. , 1991, The Journal of biological chemistry.
[41] J. Lunec,et al. Protein fluorescence and its relationship to free radical activity. , 1987, The British journal of cancer. Supplement.
[42] W. Garrison. REACTION MECHANISMS IN THE RADIOLYSIS OF PEPTIDES, POLYPEPTIDES AND PROTEINS II REACTIONS AT SIDE-CHAIN LOCI IN MODEL SYSTEMS , 1982 .
[43] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Orange,et al. Functional characterization of rat mast cell arylsulfatase activity. , 1976, Journal of immunology.
[45] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.